It takes more patience to implant stents.

Original title: Duration of Balloon Inflation for Optimal Stent Deployment: Five Seconds Is Not Enough. Reference: Thomas Hovasse et al. Catheterization and Cardiovascular Interventions 81:446–453 (2013).

Adequate stent expansion and apposition to the vessel wall is essential to optimize the results of percutaneous transluminal coronary angioplasty (PTCA).

If the above is not adequate, it increases the risk of thrombosis and restenosis for both conventional stents and DES. Currently there are no recommendations on how much time is required for balloon inflation and correct stent implantation. Intravascular ultrasound (IVUS) is the technique of choice to determine the correct stent implantation but nevertheless, is not yet possible to use it in order to determine the effect of inflation on the length of stent expansion

The StentBoost, (Philips Medical Systems, Best, the Netherlands), correlates well with IVUS and is superior to conventional angiography. The objective of this study was to assess the relationship between the length of the balloon inflation and stent deployment expansion, using the same StentBoost. We included 104 consecutive patients which underwent PTCA in de novo lesions with stent expansion measured at 5, 15 and 25 seconds using StentBoost. Cypher stents (54%), Xience V (30.6%) and Taxus Liberté (15.3%) were used.

The duration of the insufflation significantly influenced stent expansion. After 5 seconds the minimum diameter was 2.6 ± 0.51 mm, increasing to 2.76 ± 0.51 at 15 sec (p <0.0001) and reaching 2.82 ± 0.52 mm at 25 sec (p <0.0001). Although there is 29.3% still required post dilation. Applying MUSIC, (Multicenter Ultrasound Stenting in Coronaries) criteria, the proportion of under expansion stents gradually decreased from 31.3% at 5 sec distension to 3.3% at 15 seconds and finally 2% at 25 seconds (p <0.0001).

Conclusion: 

Balloon inflation time during stent release had a significant impact on stent expansion. The authors recommend blowing for at least 25 seconds in daily practice.

Editorial Comment: 

Although no IVUS was performed, which is the gold standard for assessing the proper expansion and apposition of a stent, there is evidence that the assessment with StentBoost has an acceptable correlation. These technologies are often available in the catheterization room and yet are underutilized because of the time needed. We must regain a bit of the patience we show at the time of balloon angioplasty for better expansion and apposition of the stent at this time.

SOLACI.ORG

More articles by this author

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary bifurcation lesions (CBL). Moreover, recent studies such...

Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions

The use of coronary stents vs plain old balloon angioplasty (POBA), has allowed to reduce recoil and limiting flow dissection which were major limitation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...